Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines

Sex Disparity in Response to Hepatitis B Vaccine Related to the Age of Vaccination

(2020) Andrea Trevisan et al.   International Journal of Environmental Research and Public Health

Vaccination with Fendrix of prior nonresponding patients with HIV has a high success rate

(2019) Julian D. Machiels et al.   AIDS

Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial

(2019) Stijn F H Raven et al.   LANCET INFECTIOUS DISEASES

Willingness to Participate in Vaccine-Related Clinical Trials among Older Adults

(2018) Divyanshu Raheja et al.   International Journal of Environmental Research and Public Health

Humoral and Cellular Responses to a Single Dose of Fendrix in Renal Transplant Recipients with Non-response to Previous Hepatitis B Vaccination

(2017) M. Lindemann et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Long-term Protection After Hepatitis B Vaccine

(2016) Pierre Van Damme   JOURNAL OF INFECTIOUS DISEASES

Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose

(2016) Michael G. Bruce et al.   JOURNAL OF INFECTIOUS DISEASES

Factors influencing immunologic response to hepatitis B vaccine in adults

(2016) Shigui Yang et al.   Scientific Reports

Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus

(2016) Olivier Van Der Meeren et al.   Human Vaccines & Immunotherapeutics

Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis

(2015) Olivier Van Der Meeren et al.   Human Vaccines & Immunotherapeutics

Cost-Effectiveness of Ensuring Hepatitis B Protection for Previously Vaccinated Healthcare Personnel

(2014) Thomas J. Hoerger et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Successful use of Fendrix in HIV-infected non-responders to standard hepatitis B vaccines

(2014) Thushan I. de Silva et al.   JOURNAL OF INFECTION

Medical Virology of Hepatitis B: how it began and where we are now

(2013) Wolfram H Gerlich   Virology Journal

Efficacy of a Hepatitis B Vaccination Schedule With Two Cycles of Four Double Doses of Conventional Vaccine and Four Doses of Adjuvanted Vaccine in Chronic Kidney Disease Patients Evaluated for Renal Transplantation

(2012) R. García-Agudo et al.   TRANSPLANTATION PROCEEDINGS

Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders

(2012) Christian J.P.A. Hoebe et al.   VACCINE

Hepatitis B and the Need for a Booster Dose

(2011) E. Leuridan et al.   CLINICAL INFECTIOUS DISEASES

Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients

(2008) Jiri Beran   EXPERT OPINION ON BIOLOGICAL THERAPY